Stereotactic Body Radiation Therapy in Centrally and Superiorly Located Stage I or Isolated Recurrent Non–Small-Cell Lung Cancer
- 1 November 2008
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 72 (4) , 967-971
- https://doi.org/10.1016/j.ijrobp.2008.08.001
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung CancerInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Image–Guided Radiation Therapy for Non–small Cell Lung CancerJournal of Thoracic Oncology, 2008
- Steep Dose–Response Relationship for Stage I Non–Small-Cell Lung Cancer Using Hypofractionated High-Dose Irradiation by Real-Time Tumor-Tracking RadiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Stereotactic Body Radiation Therapy for Stage I Non–Small Cell Lung CancerThoracic Surgery Clinics, 2007
- Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung CancerJournal of Clinical Oncology, 2006
- Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non–small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frameInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I studyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinomaCancer, 2004